Heart Failure

If you have heart failure, your heart is not strong enough to pump blood effectively to the rest of your body. As your heart struggles to work harder, it may become enlarged. You may feel shortness of breath and feel tired when you exert yourself. NewYork-Presbyterian is renowned for our team of specialists with exceptional experience treating people with all types and stages of heart failure.

Experts in the Care of Heart Failure

We bring together all of the specialists you need. Our team includes surgeons and cardiologists specializing in heart failure, along with appropriate consultants, ICU intensivists, pharmacists, nurses and nurse practitioners, nutritionists, physical therapists, and social workers. We personalize your treatment, offering medications to support your heart's function, investigate potentially reversible causes, treat necessary associated medical conditions and, if you need conventional cardiac surgery, valve replacement, heart transplant, a cardiac assist device, or ECMO therapy.

The Nation's Largest Heart Transplant Program

If you have end-stage heart failure and do not respond to medical treatment, you may be a candidate for a heart transplant. Our Heart Failure and Transplantation Program is the largest and most active heart transplant program in the nation, with more than 100 heart transplants performed each year. Survival rates among our patients have consistently met or exceeded the national average since our program's inception. People come to us from all over the country for our care. More than 2,300 adult and pediatric heart transplants have been performed at NewYork-Presbyterian since 1988.

Excellent Heart Failure Outcomes

NewYork-Presbyterian has a 91-percent inpatient survival rate in patients undergoing care for advanced heart failure and a 30-day mortality rate—28 percent lower than the national average.

ECMO to Support Heart Function

Our adult Extracorporeal Membrane Oxygenation (ECMO) Program is one of the largest in the world. ECMO is a device that supports a patient’s circulation when the heart fails, as can occur after a heart attack, because of a virus, or as can be seen with advanced cardiomyopathy among other causes. ECMO is used for patients with the greatest degree of circulatory failure and can be a means to support the patient while the heart recovers, or until another surgery can be performed such as implantation of a left ventricular assist device (mechanical heart pump) or a heart transplant.

Leaders in the Use of Ventricular Assist Devices (VADs)

For more than 25 years, NewYork-Presbyterian has been a pioneer in the field of mechanical support for people with advanced heart failure. Our Mechanical Circulatory Support Program has been helping patients benefit from VADs since 1990. Across both the Columbia and Cornell campuses, surgeons have implanted more than 1100 LVADs as destination therapy or as a bridge to transplantations. Our surgeons have played an integral role in the development of many groundbreaking devices, and perform one to two VAD implantations each week—one of the largest volumes nationwide—with survival rates that exceed the national average. To overcome long waiting lists for donor organs and other limitations, we have spearheaded an international effort to develop VADs that provide mechanical support for failing hearts. Our VAD specialists follow you closely after you receive your device to monitor your health and provide support and education about living with a VAD.

Bridge-to-Transplant and Destination Therapies

A VAD can help you stabilize or improve if you're waiting for a heart transplant, enabling you to live a productive life at home while waiting for a heart donor. If you have end-stage heart failure and a heart transplant is not possible due to your age or other health problems, long-term "destination therapy" with a VAD can help you function better and live a longer, productive life. Research conducted at NewYork-Presbyterian has demonstrated that people with the implanted HeartMate VAD as destination therapy lived longer and had a better quality of life than people who were treated with medication and were medically monitored.

Clinical Trials Offering New Ventricular Assist Devices

We participate in national clinical trials of innovative VADs for people with heart failure. NewYork-Presbyterian investigators have led major clinical trials that have defined the standard of care for heart failure. You may have the opportunity to participate in a clinical trial of an innovative heart failure treatment.

Contact

TO FIND A DOCTOR

877-NYP-WELL (877-697-9355)